Tor B. Stuge

3.1k citations
43 papers · 2.5k indexed · h-index 24
Topics
T-cell and B-cell Immunology (16 papers)Immune Cell Function and Interaction (15 papers)Platelet Disorders and Treatments (13 papers)

In The Last Decade

Tor B. Stuge

43 papers receiving 2.4k citations

Peers

Tor B. Stuge
Comparison fields: 5 of 98
  • Immunology 2.0k
  • Molecular Biology 635
  • Oncology 560
  • Hematology 218
  • Genetics 211
Replace Marilyn Diaz with:
Marilyn Diaz United States
Lili Xu China
Judy Bastin United Kingdom
Roberto Marzari Italy
T Nakagawa United States
Kanako L. Lewis United States
Andrew Getahun United States
Jhagvaral Hasbold Australia
Ronald B. Corley United States
Xavier Romero Spain
Tor B. Stuge relative to Marilyn Diaz United States Marilyn Diaz's profile →
Citations per field
00.5×3.5×
Marilyn Diaz · 1×
Citations per year

Countries citing papers authored by Tor B. Stuge

Since Specialization
Citations

This map shows the geographic impact of Tor B. Stuge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor B. Stuge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor B. Stuge more than expected).

Fields of papers citing papers by Tor B. Stuge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor B. Stuge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor B. Stuge. The network helps show where Tor B. Stuge may publish in the future.

Co-authorship network of co-authors of Tor B. Stuge

This figure shows the co-authorship network connecting the top 25 collaborators of Tor B. Stuge. A scholar is included among the top collaborators of Tor B. Stuge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor B. Stuge. Tor B. Stuge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 18
2 24
3 13
4 19
5 10
6 20
7 31
8 105
9 14
10 73
11 328
12 138
13 22
14 67
15 310
16 95
17 27
18 96
19 50
20 62

About Tor B. Stuge

Tor B. Stuge is a scholar working on Immunology, Hematology and Immunology and Allergy, having authored 43 papers that have together received 2.5k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (15 papers) and Platelet Disorders and Treatments (13 papers). The work is most often cited by research in Immunology (2.0k citations), Oncology (560 citations) and Hematology (218 citations). Tor B. Stuge has collaborated with scholars based in United States, Norway and United Kingdom. Frequent co-authors include Peter P. Lee, Norman W. Miller, L. William Clem, Jeffrey S. Weber, Eva Bengtén, Melanie Wilson, Mario Roederer, Michael R. Betts, Naileshni Singh and V. Gregory Chinchar. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026